Myint et al., 2009 - Google Patents
Polar anionic metabolome analysis by nano-LC/MS with a metal chelating agentMyint et al., 2009
- Document ID
- 5402428044647808002
- Author
- Myint K
- Uehara T
- Aoshima K
- Oda Y
- Publication year
- Publication venue
- Analytical chemistry
External Links
Snippet
We have developed a practical method for the comprehensive analysis of polar anionic metabolites in biological samples with the use of a nano-LC/MS system. A polyamine- bonded polymer-based apHera NH2 column, which is compatible with ammonium …
- 238000004895 liquid chromatography mass spectrometry 0 title abstract description 59
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Myint et al. | Polar anionic metabolome analysis by nano-LC/MS with a metal chelating agent | |
Hsiao et al. | Improved LC/MS methods for the analysis of metal-sensitive analytes using medronic acid as a mobile phase additive | |
Shi et al. | Database-assisted globally optimized targeted mass spectrometry (dGOT-MS): broad and reliable metabolomics analysis with enhanced identification | |
Tada et al. | Correlation-based deconvolution (CorrDec) to generate high-quality MS2 spectra from data-independent acquisition in multisample studies | |
Mahieu et al. | Credentialing features: a platform to benchmark and optimize untargeted metabolomic methods | |
Wood | Mass spectrometry strategies for clinical metabolomics and lipidomics in psychiatry, neurology, and neuro-oncology | |
Bienvenu et al. | Standardized procedure for the simultaneous determination of the matrix effect, recovery, process efficiency, and internal standard association | |
Guo et al. | Differential 12C-/13C-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome | |
Li et al. | Quantitation of endogenous analytes in biofluid without a true blank matrix | |
Winnike et al. | Comparison of GC-MS and GC× GC-MS in the analysis of human serum samples for biomarker discovery | |
Bogialli et al. | Rapid confirmatory assay for determining 12 sulfonamide antimicrobials in milk and eggs by matrix solid-phase dispersion and liquid chromatography− mass spectrometry | |
Spalding et al. | Trace phosphate improves ZIC-pHILIC peak shape, sensitivity, and coverage for untargeted metabolomics | |
Gu et al. | Monitoring diet effects via biofluids and their implications for metabolomics studies | |
Xue et al. | Enhanced in-source fragmentation annotation enables novel data independent acquisition and autonomous METLIN molecular identification | |
Nagy et al. | Monosaccharide identification as a first step toward de novo carbohydrate sequencing: mass spectrometry strategy for the identification and differentiation of diastereomeric and enantiomeric pentose isomers | |
Smith et al. | Sensitive and reproducible mass spectrometry-compatible RP-UHPLC analysis of tricarboxylic acid cycle and related metabolites in biological fluids: application to human urine | |
Hu et al. | Nontargeted screening and determination of sulfonamides: a dispersive micro solid-phase extraction approach to the analysis of milk and honey samples using liquid chromatography–high-resolution mass spectrometry | |
Lee et al. | Multiple precursor ion scanning of gangliosides and sulfatides with a reversed-phase microfluidic chip and quadrupole time-of-flight mass spectrometry | |
Zhang et al. | Enhancing the power of liquid chromatography–mass spectrometry-based urine metabolomics in negative ion mode by optimization of the additive | |
Veach et al. | Rapidfire mass spectrometry with enhanced throughput as an alternative to liquid–liquid salt assisted extraction and LC/MS analysis for sulfonamides in honey | |
Wang et al. | Matrix effects in analysis of β-agonists with LC-MS/MS: influence of analyte concentration, sample source, and SPE type | |
Widner et al. | Quantification of amine-and alcohol-containing metabolites in saline samples using pre-extraction benzoyl chloride derivatization and ultrahigh performance liquid chromatography tandem mass spectrometry (UHPLC MS/MS) | |
González et al. | Matrix effect compensation in small-molecule profiling for an LC–TOF platform using multicomponent postcolumn infusion | |
Liu et al. | An evidence‐based review of related metabolites and metabolic network research on cerebral ischemia | |
Wang et al. | Ion trace detection algorithm to extract pure ion chromatograms to improve untargeted peak detection quality for liquid chromatography/time-of-flight mass spectrometry-based metabolomics data |